Mobile

Clinical Trial to compare the efficacy and safety of masitinib to placebo in patients with localized, primary Gastrointestinal Stromal Tumor (GIST) after complete surgery and with high risk of recurre...

Update Il y a 4 ans
Reference: EUCTR2013-004162-34

Clinical Trial to compare the efficacy and safety of masitinib to placebo in patients with localized, primary Gastrointestinal Stromal Tumor (GIST) after complete surgery and with high risk of recurrence Esnsayo para comparar la eficacia y seguridad de masitinib versus placebo en pacientes con tumor del estroma gastrointestinal (GIST) primario y localizado tras cirugía mayor y con alto riesgo de recurrencia

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The objective is to compare the efficacy of masitinib at 4.5 mg/kg/day to placebo El objetivo es comparar la eficacia de masitinib a la dosis 4,5 mg / kg/día con cambio a 6 mg/kg/día tras 12 semanas de tratamiento comparado con placebo en pacientes con GIST localizado y primario después de una cirugía completa y con alto riesgo de recidiva.

Inclusion criteria

  • stromal gastrointestinal cancer,Tumor del estroma gastrointestinal

Links